US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

250.40

-17.9900-6.70%

Post-market: 251.981.58+0.63%19:59 EDT

Volume:325.61K

Turnover:81.61M

Market Cap:494.41M

PE:- -

High:267.90

Open:266.14

Low:243.24

Close:268.39

52wk High:341.93

52wk Low:76.29

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.30

T/O Rate:16.49%

Dividend:1.02

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Aurobindo Pharma's API Unit Receives One US FDA Observation

MT Newswires Live

EBR Systems Plans FDA Label Update for WiSE System in Q4

MT Newswires Live

Emyria takes Australian psychedelic treatment model to U.S. FDA

Dimerix to Showcase Kidney Disease Pipeline and Growth Strategy at E&P Healthcare Conference

Beta Bionics Secures FDA Clearance for Mint Patch Pump

Health Care Down, but not by Much, on Rotation to Less Inflation-Sensitive Areas

Indivior accelerates transition from RB manufacturing agreement

Health Care Roundup: Market Talk

Spectral AI advances DeepView burn diagnostics after FDA nod

Scholar Rock says FDA requested pregnancy safety study for Isembyld

Veradigm Unveils Transformation Strategy at Investor Conferences

NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’

NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine

Revolution Medicines gets orphan designation for pancreatic cancer treatment

Scholar Rock Faces Early Isembyld Launch Friction From FDA Safety Requirements, Truist Says

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Veeva Systems (VEEV), Mereo Biopharma Group Plc (MREO) and Tvardi Therapeutics (TVRD)

Tenet Healthcare Director Sells Stock for $2.6 Million

MT Newswires Live

Twist Bioscience says Anthropic pilot work factored in FY27 orders expectations

Nestmedic’s PregnaOne 510(k) Moves Into Substantive FDA Review

Sector Update: Healthcare

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LABU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":250.4,"timestamp":1789502400000,"preClose":268.39,"halted":0,"volume":325606,"hourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"delay":0,"changeRate":-0.0670293230001117,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Closed","change":-17.99,"latestTime":"09-15 16:00:00 EDT","open":266.14,"high":267.9,"low":243.2444,"amount":81609965.98544,"amplitude":0.091865,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":268.39,"sharesOutstanding":3074486,"nav":268.659,"aum":530464172.89,"dividendRate":0.00407,"bidAskSpread":0.003539,"preHourTrading":{"tag":"盘前","latestPrice":267.7,"preClose":268.39,"latestTime":"09:25 EDT","volume":476,"amount":126913.024,"timestamp":1789478754552,"change":-0.69,"changeRate":-0.002571,"amplitude":0.027721},"postHourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"volumeRatio":1.297319,"impliedVol":0.9273,"impliedVolPercentile":0.5657},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.297319,"shares":1974486,"dividePrice":1.0191,"high":267.9,"amplitude":0.091865,"preClose":268.39,"low":243.2444,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":250.4,"eps":0,"divideRate":0.00407,"volume":325606,"delay":0,"ttmEps":0,"open":266.14,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":293.07,"twentyDayClose":287.3,"sixtyDayClose":206.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667760666","title":"Aurobindo Pharma's API Unit Receives One US FDA Observation","url":"https://stock-news.laohu8.com/highlight/detail?id=2667760666","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667760666?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:14","pubTimestamp":1789524853,"startTime":"0","endTime":"0","summary":"Aurobindo Pharma  said a U.S. FDA inspection of its API manufacturing facility in Telangana concluded with one procedural observation, according to a Tuesday exchange filing.The inspection of Unit-2 of wholly owned subsidiary Apitoria Pharma was conducted from Sept. 7 to Sept. 15, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OTX.SI","BK4588","LABU","BK4585","BK6100","BK6520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462017","title":"EBR Systems Plans FDA Label Update for WiSE System in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462017","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462017?lang=en_us&edition=fundamental","pubTime":"2026-09-16 07:31","pubTimestamp":1789515117,"startTime":"0","endTime":"0","summary":"EBR Systems  plans to submit a changes being effected  premarket approval supplement to the US Food and Drug Administration  in the fourth quarter to proactively update the WiSE System's commercial labelling, with greater emphasis on echo-induced pacing risks and mitigation strategies, according to a Wednesday filing with the Australian bourse.The company said it met with the FDA to discuss the plan, responded to the regulator's questions, and secured agreement on the proposed approach, per the filing.The CBE pathway will enable labelling safety enhancements to be implemented during the review process, helping support patient safety as commercial rollout of the WiSE System expands, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK4585","CBE.AU","LABU","BK7095","BK4588","EBR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667620262","title":"Emyria takes Australian psychedelic treatment model to U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667620262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667620262?lang=en_us&edition=fundamental","pubTime":"2026-09-16 07:28","pubTimestamp":1789514883,"startTime":"0","endTime":"0","summary":"Emyria Ltd ( ($AU:EMD) ) has issued an announcement. Emyria Limited, an Australian leader in innovative mental health treatments, specialises in ps...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/emyria-takes-australian-psychedelic-treatment-model-to-u-s-fda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/emyria-takes-australian-psychedelic-treatment-model-to-u-s-fda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","MNTL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667203276","title":"Dimerix to Showcase Kidney Disease Pipeline and Growth Strategy at E&P Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667203276","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667203276?lang=en_us&edition=fundamental","pubTime":"2026-09-16 07:00","pubTimestamp":1789513209,"startTime":"0","endTime":"0","summary":"An update from Dimerix Limited ( ($AU:DXB) ) is now available. Dimerix Limited will present its strategic and clinical progress at the E&P Healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dimerix-to-showcase-kidney-disease-pipeline-and-growth-strategy-at-ep-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dimerix-to-showcase-kidney-disease-pipeline-and-growth-strategy-at-ep-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","BK4137","HCSG","BK4581","XBI","LABU","LU0128526141.USD","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667622791","title":"Beta Bionics Secures FDA Clearance for Mint Patch Pump","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622791","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622791?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:19","pubTimestamp":1789507159,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ( ($BBNX) ) just unveiled an announcement. On September 14, 2026, Beta Bionics announced U.S. FDA clearance for Mint, a patch pu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-bionics-secures-fda-clearance-for-mint-patch-pump?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-bionics-secures-fda-clearance-for-mint-patch-pump?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BBNX","LABU","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667062221","title":"Health Care Down, but not by Much, on Rotation to Less Inflation-Sensitive Areas","url":"https://stock-news.laohu8.com/highlight/detail?id=2667062221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667062221?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:19","pubTimestamp":1789507140,"startTime":"0","endTime":"0","summary":"Health-care companies fell, but not by as much as the broad market, as traders rotated into a sector less susceptible to inflation and interest-rate concerns.Cancer-treatment developer Legend Biotech plans to name Novartis executive Ingrid Zhang as chief executive.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667622780","title":"Indivior accelerates transition from RB manufacturing agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622780?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:05","pubTimestamp":1789506300,"startTime":"0","endTime":"0","summary":"An update from Indivior ( ($INDV) ) is now available. On September 9, 2026, Indivior UK Limited and Reckitt Benckiser Healthcare (UK) Limited agree...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-accelerates-transition-from-rb-manufacturing-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-accelerates-transition-from-rb-manufacturing-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","EES","LABU","BK4007","INDV","UK","BK4528","BK4581","XBI","BK4233","BK4205","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667662266","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2667662266","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667662266?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:50","pubTimestamp":1789505400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0607 ET - AstraZeneca has a robust and diverse portfolio, with s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","XBI","XLV","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667622311","title":"Spectral AI advances DeepView burn diagnostics after FDA nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622311","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622311?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:36","pubTimestamp":1789504603,"startTime":"0","endTime":"0","summary":"Spectral AI ( ($MDAI) ) just unveiled an announcement. On May 21, 2026, Spectral AI received FDA De Novo classification for its DeepView System, au...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/spectral-ai-advances-deepview-burn-diagnostics-after-fda-nod?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/spectral-ai-advances-deepview-burn-diagnostics-after-fda-nod?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIPO","QTOC","VTHR","CHAT","LABU","ARTY","AGIX","BMED","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624691","title":"Scholar Rock says FDA requested pregnancy safety study for Isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624691","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624691?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:55","pubTimestamp":1789502119,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) disclosed earlier today on a live audio webcast yesterday announcing the Food and Drug Administration has approved Isembyld, th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-says-fda-requested-pregnancy-safety-study-for-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-says-fda-requested-pregnancy-safety-study-for-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","SRRK","BK4139","THNR","IBRN","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667246116","title":"Veradigm Unveils Transformation Strategy at Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2667246116","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667246116?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:47","pubTimestamp":1789501651,"startTime":"0","endTime":"0","summary":"Veradigm ( ($MDRX) ) has issued an announcement. On September 15–16, 2026, Veradigm presented its investor deck at the Jefferies Healthcare Service...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/veradigm-unveils-transformation-strategy-at-investor-conferences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/veradigm-unveils-transformation-strategy-at-investor-conferences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","XBI","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621742","title":"NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621742?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:15","pubTimestamp":1789499711,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals (NRXP) announced that it has received a written communication from the Director of Regulatory Operations of the FDA Office of G...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-says-fda-reclassifies-anda-amendment-to-minor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-says-fda-reclassifies-anda-amendment-to-minor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRXP","PSIL","BK4585","BK4588","LABU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624858","title":"NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624858","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624858?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:11","pubTimestamp":1789499460,"startTime":"0","endTime":"0","summary":"Abbreviated New Drug Application (ANDA) Amendment related to the drug vial for preservative-free ketamine has been reclassified from a Major Amendment to a Minor Amendment.FDA has revised the Generic ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362609/0/en/nrx-pharmaceuticals-nasdaq-nrxp-reports-update-from-the-fda-revising-previous-major-amendment-to-a-minor-amendment-for-preservative-free-ketamine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","NRXP","LCLG","BK4585","BK4007","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621483","title":"Revolution Medicines gets orphan designation for pancreatic cancer treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621483","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621483?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:00","pubTimestamp":1789498813,"startTime":"0","endTime":"0","summary":"The FDA granted Revolution Medicines (RVMD)’ zoldonrasib orphan designation as a treatment of pancreatic cancer. Published first on TheFly – the ul...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-gets-orphan-designation-for-pancreatic-cancer-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-gets-orphan-designation-for-pancreatic-cancer-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BBH","RVMD","IE00B2B36J28.USD","LU0109394709.USD","CANC","BK4139","IE00BJT1NW94.SGD","PTH","BK4585","IE0002141913.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IDNA","IE0009354923.USD","IE0009355771.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667962190","title":"Scholar Rock Faces Early Isembyld Launch Friction From FDA Safety Requirements, Truist Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667962190","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667962190?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:52","pubTimestamp":1789498323,"startTime":"0","endTime":"0","summary":"Scholar Rock  could face some friction during the early commercialization of Isembyld after the drugmaker clarified that the US Food and Drug Administration has required a post-marketing pregnancy safety study and requested 15-day reports for serious and non-serious fracture cases, Truist Securities said in a note Tuesday.The FDA recently approved Isembyld to treat spinal muscular atrophy in adults and children two years of age and older.The fracture rate observed in the Isembyld trial appears consistent with historical rates in patients with spinal muscular atrophy, while management reported no change in bone mineral density in the Phase 2 EMBRACE study, Truist said.The brokerage expects fracture reports to be reflected in periodic FDA Adverse Event Reporting System updates, as Scholar Rock does not expect to announce individual new fracture cases.Truist continues to see potential for Isembyld to reach peak sales of $2.3 billion.Truist maintained a buy rating with $76 price target.Pri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","BK4585","THNR","SRRK","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667455621","title":"Analysts Conflicted on These Healthcare Names: Veeva Systems (VEEV), Mereo Biopharma Group Plc (MREO) and Tvardi Therapeutics (TVRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667455621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667455621?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:50","pubTimestamp":1789498210,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Veeva Systems (VEEV), Mereo Biopharma Group Plc (M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-veeva-systems-veev-mereo-biopharma-group-plc-mreo-and-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-veeva-systems-veev-mereo-biopharma-group-plc-mreo-and-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","BK4613","LU0289739699.SGD","LABU","LU1989764664.SGD","LU0006306889.USD","LU0029874061.USD","LU0170899867.USD","BK4534","LGHT","LU0266013472.USD","BK4528","XBI","LU1989764748.USD","BK4505","EKG","HCSG","MREO","XLV","LU0106261372.USD","BK4588","BK4504","BK4139","VEEV","BK4167","BK4007","TVRD","LU0128526141.USD","BK4581","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621583","title":"Tenet Healthcare Director Sells Stock for $2.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621583","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621583?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:28","pubTimestamp":1789496881,"startTime":"0","endTime":"0","summary":"Tenet Healthcare  shares were down 1.3% in Tuesday trading, a day after the company said in a filing that board member Richard Mark sold 10,000 common shares at $263.42 each on Sept. 10, for total proceeds of approximately $2.6 million.Mark currently owns 25,121 shares of Tenet Healthcare, according to the filing.Price: 260.90, Change: -3.61, Percent Change: -1.36","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["THC.AU","BK4581","LU1201861165.SGD","LU0029874061.USD","LU0963586101.USD","XLV","HCSG","BK4137","LU2324357040.USD","THC","BK4185","LU0648000940.SGD","XBI","BK4585","LU0128526141.USD","LU0130103400.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621367","title":"Twist Bioscience says Anthropic pilot work factored in FY27 orders expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621367?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:05","pubTimestamp":1789495511,"startTime":"0","endTime":"0","summary":"Emily Leproust, the co-founder and CEO of Twist, was asked while presenting at the Baird Global Healthcare Conference about Twist having recently b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/twist-bioscience-says-anthropic-pilot-work-factored-in-fy27-orders-expectations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/twist-bioscience-says-anthropic-pilot-work-factored-in-fy27-orders-expectations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4585","LABU","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629626","title":"Nestmedic’s PregnaOne 510(k) Moves Into Substantive FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629626","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629626?lang=en_us&edition=fundamental","pubTime":"2026-09-16 01:17","pubTimestamp":1789492658,"startTime":"0","endTime":"0","summary":"Nestmedic SA ( ($PL:NST) ) has provided an update. Nestmedic has moved to a new phase in its U.S. regulatory push, as the Food and Drug Administrat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nestmedics-pregnaone-510k-moves-into-substantive-fda-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nestmedics-pregnaone-510k-moves-into-substantive-fda-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629828","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629828","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629828?lang=en_us&edition=fundamental","pubTime":"2026-09-16 01:05","pubTimestamp":1789491915,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Tuesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each increasing about 0.1%.The iShares Biotechnology ETF  was down 1%.In corporate news, GSK  agreed to acquire global rights to an experimental T-cell engager therapy for multiple myeloma from Chinese biotechnology company Chimagen Biosciences in a deal worth up to $750 million, as the UK drugmaker aims to strengthen its blood cancer treatment portfolio. GSK shares were up 0.1%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSKH","HCSG","BK4588","BK4585","BK4532","LABU","LU0029874061.USD","IBB","LU1829250122.USD","XBI","BK4007","BK4581","BK4137","GSK","LU0128526141.USD","GSK.UK","XLV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":1,"totalSize":427,"code":"91000000","status":"200"}]}}